Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary
kidney disease and one of the most common causes of end-stage kidney disease. Multiple …

Autosomal-dominant polycystic kidney disease (ADPKD) affects up to 12 million individuals
and is the fourth most common cause for renal replacement therapy worldwide. There have …

Polycystic kidney disease (PKD) is a leading cause of ESRD worldwide. In PKD, excessive
cell proliferation and fluid secretion, pathogenic interactions of mutated epithelial cells with …

Background Autosomal dominant polycystic kidney disease slowly progresses to end-stage
renal disease and has no effective therapy. A pilot study suggested that the somatostatin …

Polycystic liver disease (PLD) is the result of embryonic ductal plate malformation of the
intrahepatic biliary tree. The phenotype consists of numerous cysts spread throughout the …

Polycystic liver disease (PLD) is arbitrarily defined as a liver that contains> 20 cysts. The
condition is associated with two genetically distinct diseases: as a primary phenotype in …

Hepatic cysts are increasingly found as a mere coincidence on abdominal imaging
techniques, such as ultrasonography (USG), computed tomography (CT) and magnetic …

Autosomal-dominant polycystic kidney disease (ADPKD) is a systemic disease, marked by
progressive increase of bilateral renal cysts, resulting in chronic kidney disease (CKD) and …

Importance Autosomal dominant polycystic kidney disease (ADPKD) is characterized by
progressive cyst formation in both kidneys and loss of renal function, eventually leading to a …

Polycystic liver disease (PLD) is a group of genetic disorders characterized by progressive
development of cholangiocyte-derived fluid-filled hepatic cysts. PLD is the most common …